| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Difficult Staff - It Pays To Get To Know Them Better |
|
Just Other Articles - Difficult Staff - It Pays To Get To Know Them Better
It's very easy for a business owner or manager to fall into
the trap of condemning one of their According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product team as a no-hoper or a
problem child. It may turn out that this person shouldn't be on your ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in eam
however as Abraham Lincoln once said about someone he had a
problem with -
"I don't thin lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. k I like that man, I must get to know him
better." Of course, we're not just talking about dif here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe icult members of
your team; we're talking about all of them and how important
it is to underst d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro and them as individuals.
It's important because it's important to them. As Dr Phillip C McGra ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc says in his book - Life Strategies -
"The number one need among all people is acceptance."
Yo easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ur team want to know that you accept them from a work
point of view but they also want you to a nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically cept them just for
who they are. Find out as much as you can about your team; their backgroun and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ d, where they're from, families, pets hobbies,
sports and their views on the world.
Find out ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi heir philosophies and faiths; how they think and
how they feel. Just think about it like any ot ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a her
relationship - what do you want to know about this person? Now I'm not suggesting you sit dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod round all day gazing into
each others eyes or spend half the night on the phone. I'm
suggestin cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin g you do this over time and slowly but surely,
build up your understanding of this person.
I tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen lso know that you're starting to get a bit nervous about
this and might think its prying. You t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel might also be thinking that your team members won't want
you to get to know them that well. Wel ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust let me reassure you
- most of them will if it's done discretely.
Almost everyone wants to kn y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ow that someone is genuinely and
positively interested in them. They may not always give that
. As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de mpression by their demeanour but trust me - they want to
know you care; they want acceptance fr elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip om you.
If they know you care about them, then your relationship
will be much more productive tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:If You're a Struggling Scientist, a Shortcut to a Lucrative Career in Patent Law Awaits You Customer Service Expert Says: Setting An Appropriate Tone Is Crucial
|